Flash electroretinogram and addictive disorders

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 56, Issue , 2015, Pages 264-

  Laprevote, Vincent ^a   Schwitzer, Thomas ^b,c   Giersch, Anne ^c   Schwan, Raymund ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Biomarker; Cannabis; Electroretinogram; Retina

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; TETRAHYDROCANNABINOL;

ADDICTION; CANNABIS USE; COGNITIVE DEFECT; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; FUNCTIONAL ASSESSMENT; HUMAN; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NOTE; REPRODUCIBILITY; RETINA GANGLION CELL; SUBSTANCE ABUSE; VISUAL SYSTEM FUNCTION; ANIMAL; BRAIN; MENTAL DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY; RETINA;

ANIMALS; BRAIN; HUMANS; MENTAL DISORDERS; RETINA;

EID: 84920161430     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.04.005     Document Type: Note

References (11)

1. Cécyre B., Zabouri N., Huppé-Gourgues F., Bouchard J.-F., Casanova C. Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice. Invest Ophthalmol Vis Sci 2013, 54(13):8079-8090. [Dec].
2. Chen J., Matias I., Dinh T., Lu T., Venezia S., Nieves A., et al. Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem Biophys Res Commun 2005, 330(4):1062-1067. [May 20].
3. Dawson W.W., Jiménez-Antillon C.F., Perez J.M., Zeskind J.A. Marijuana and vision-after ten years' use in Costa Rica. Invest Ophthalmol Vis Sci 1977, 16(8):689-699. [Aug].
4. Fan S.-F., Yazulla S. Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Vis Neurosci 2003, 20(2):177-188. [Apr].
5. Lavoie J., Maziade M., Hébert M. The brain through the retina: the flash electroretinogram as a tool to investigate psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2014, 3(48):129-134. [Jan].
6. Marmor M.F., Fulton A.B., Holder G.E., Miyake Y., Brigell M., Bach M., et al. ISCEV standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 2008, 118(1):69-77. [Nov 22].
7. Matias I., Wang J.W., Moriello A.S., Nieves A., Woodward D.F., Di Marzo V. Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids 2006, 75(6):413-418. [Dec].
8. Middleton T.P., Protti D.A. Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. Vis Neurosci 2011, 28(05):393-402. [Jul 12].
9. Porcella A., Maxia C., Gessa G.L., Pani L. The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein. Eur J Neurosci 2000, 12(3):1123-1127. [Mar].
10. Straiker A.J., Maguire G., Mackie K., Lindsey J. Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci 1999, 40(10):2442-2448. [Sep].
11. West M.E. Cannabis and night vision. Nature 1991, 351(6329):703-704. [Jun 27].